COMPUTATIONAL SCREENING AND QSAR STUDY ON A SERIES THEOPHYLLINE DERIVATIVES AS ALDH1A1 INHIBITORS

Authors

  • F. Z. Fadel Laboratoire d’Ingénierie des Procédés et de l’Environnement (LIPE), Faculté de Chimie, Université des Sciences et de la Technologie d’Oran Mohamed BOUDIAF, USTO-MB, BP 1503, El M’naouer, 31000 Oran, Algérie
  • N. Tchouar Laboratoire d’Ingénierie des Procédés et de l’Environnement (LIPE), Faculté de Chimie, Université des Sciences et de la Technologie d’Oran Mohamed BOUDIAF, USTO-MB, BP 1503, El M’naouer, 31000 Oran, Algérie
  • S. Belaidi Group of Computational and Medicinal Chemistry, Laboratory of Molecular Chemistry and environment, Department of Chemistry , University of Biskra
  • F. Soualmia Laboratoire d’Ingénierie des Procédés et de l’Environnement (LIPE), Faculté de Chimie, Université des Sciences et de la Technologie d’Oran Mohamed BOUDIAF, USTO-MB, BP 1503, El M’naouer, 31000 Oran, Algérie
  • O. Oukil Laboratoire d’Ingénierie des Procédés et de l’Environnement (LIPE), Faculté de Chimie, Université des Sciences et de la Technologie d’Oran Mohamed BOUDIAF, USTO-MB, BP 1503, El M’naouer, 31000 Oran, Algérie
  • K. Ouadah Laboratoire d’Ingénierie des Procédés et de l’Environnement (LIPE), Faculté de Chimie, Université des Sciences et de la Technologie d’Oran Mohamed BOUDIAF, USTO-MB, BP 1503, El M’naouer, 31000 Oran, Algérie

DOI:

https://doi.org/10.4314/jfas.v13i2.17

Keywords:

Theophylline , ALDH1A1 inhibitor,SAR, QSAR,ANN, MLR.

Abstract

In the present study, we explored a series of molecules with anticancer activity, so that qualitative and quantitative studies of the structure-activity relationship (SAR/QSAR) were performed on seventeen theophylline derivatives. These are inhibitors of ALDH1A1. The present study shows the importance of quantum chemical descriptors, constitutional descriptors and hydrophobicity to develop a better QSAR model, whose studied descriptors are LogP, MW, Pol, MR, S, V, HE, DM, EHOMO and ELUMO. A multiple linear regression (MLR) and artificial neural networks (ANN) procedure was used to design the relationships between molecular descriptors and the inhibition of ALDH1A1 by theophylline derivatives. The validation and good quality of the QSAR model are confirmed by a strong correlation between experimental and predicted activity.

Downloads

Download data is not yet available.

References

1. S. Yang, A. Yasgar, B. Miller, M. Lal-Nag, K. Brimacombe, X.Hu, H.Sun, A. Wang, X. Xu, K.Nguyen, U. Oppermann, M. Ferrer, V. Vasiliou, A. Simeonov, A. Jadhav, and D. Maloney, J. Med. Chem. 58,15(2015).
2. P.J. Barnes, J. Respir. Crit. Care Med.,167, 813 (2003).
3. P. Ambure, R. B. Aher, A. Gajewicz, T. Puzyn, and K. Roy, J. Chemom. Intell. Lab. Syst.,147 ,1(2015).
4. E. Pindelska, A. Sokal, L. Szeleszczuk, D.M. Pisklak, and W. Kolodziejski, J. pba., 100,322 (2014).
5. T. Fujita, D.A. Winkler, J. Mol. Struct., 56,269 (2016).
6. V.H. Masand, N.N.E. El-Sayed, M.U. Bambole, and V.R. Patil, J. Mol. Struct. 1175,481 (2019).
7. D. M. Segall, J. Curr. Pharm. Des. 18, 1292 (2012).
8. D. F. Veber, S. R. Johnson, H. Y. Cheng, B. R. Smith, K. W. Ward,and K. D. Kopple, J. Med. Chem. 45, 2615 (2002).
9. C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feency,J. Adv. Drug Delivery Rev. 64, 4 (2012).
10. A. Zerroug, S. Belaidi, I. Benbrahim, L. Sinha, S. Chtita, J. JKSUS.03,024(2018).
11. O. Oukil, N.Tchouar, S.Belaidi, T. Salah, and M.Cinar, Rev. Roum. Chim. 62, 75 (2017).
12. M. Ghamali, S. Chtita, A. Ousaa, B. Elidrissi, M. Bouachrine, T. Lakhlifi, J. TUSCI. 11(2017).
13. HyperChem (Molecular Modeling System) Hypercube, Inc., 1115 NW, 4th Street, Gainesville, FL 32601, USA (2008).
14. Gaussian 09, M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery, J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. Staroverov, T. Keith, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, N. Rega, J. M. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K. Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, O. Farkas, J. B. Foresman, J. V. Ortiz, J. Cioslowski, and D. J. Fox, Gaussian Inc., Wallingford, CT (2010).
15. Database, [http://www. Molinspiration.com]
16. S. Khamouli, S. Belaidi, Z. Almi, S. Medjahed, and H. Belaidi, J. Bionanosci. 11, 301 (2017).
17. D. F. Veber, S. R. Johnson, H. Y. Cheng, B. R. Smith, K. W. Ward, and K. D. Kopple, J. Med. Chem. 45, 2615 (2002).
18. V. N. Viswanadhan, A. K. Ghose, G. R. Revankar, and R. K. Robins, J. Chem. Inform. Comput. Sci. 29, 1631 (1989).
19. A. K. Ghose and G. M. Crippen, J. Chem. Inf. Comput. Sci. 27, 21 (1987).
20. A. Gavezzotti, J. Am. Chem. Soc. 105, 5220 (1983).
21. N. Bodor, Z. Gabanyi, and C. K. Wong, J. Am. Chem. Soc. 111, 3783 (1989).
22. T. Ooi, M. Oobatake, G. Nemeth, and H. A. Scheraga, Proc. Natl. Acad. Sci. USA 84, 3086 (1987).
23. C. W. Jiang, X. Zhou, R. H. Xie, and F. L. Li, Quantum Matter 2, 353 (2013).
24. S. K. Chang, Y. Cho, and J. I. Choe, J. Comput. Theor. Nanosci. 10, 1701 (2013).
25. K. J. Miller and J. Am. Chem. Soc. 112, 8533 (1990).
26. J. Wang, X. Q. Xie, T. Hou, and X. Xu, J. Phys. Chem. A. 111, 4443 (2007).
27. R. Darnag, B. Minaoui, M. Fakir, Arab. J. Chem. 10 (2017) 600e608.
28. JMP 8.0.2, SAS Institute Inc., (2009).
29. D. M. Segall, J. Curr. Pharm. Des.18, 1292 (2012).
30. C. A. Lipinski, F. Lombardo, B. W. Dominy and P. J. Feeney, J. Adv. Drug DeliveryRev. 64, 4 (2012)
31. R. Aurélien, “ Détermination et Caractérisation Des Cibles De DSP1 Chez DrosophilaMelanogaster ”, Ph.D. Dissertation, OrleansUniversity, (2006).
32. N. Aoumeur, N. Tchouar, S. Belaidi, S. Medjahed, O. Oukil, and T. Lanez. J. Bionanosci. 12 ,428(2018).
33. Z. Sebaa, N. Tchouar, T. Salah, H. Belaidi, Z. Almi, and S. Belaidi, J. Bionanosci. 12, 119 (2018).
34. A. Kerassa, S. Belaidi and T. Lanez, Quantum Matter. 5, 45 (2016).
35. S. Schultes, C. Graaf, E. Haaksma, J. P. Iwan, and O. Kramer, J.DrugDiscov. Today:Technologies. 7, 157 (2010).
36. N. I. Zhokhova, I. I. Baskin, V. A. Palyulin, A. N. Zefirov, and N. S. Zefirov, Russ. Chem. B 52, 1061 (2003).
37. S. Belaidi, A. Kerassa, T. Lanez, and M. Cinar, J. Comput. Theor. Nanosci. 12, 2127 (2015).
38. G. Vistoli, A. Pedretti and B. Testa, J.DrugDiscov. Today:Technologies. 13, 285 (2008).
39. M. Remko, M. Swart and F. M. Bickelhaupt, J. Bioorg. Med. Chem.14, 1715 (2006).
40. G. W. Bemis and M. A. Murcko, J. Med. Chem. 39, 2887 (1996).
41. C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeny, Adv. Drug. Deliv. Rev. 23, 3 (1997).
42. T. Singh , O. A. Adekoya, and B. Jayaram, Mol. Bio. Syst. 11, 1041 (2015).
43. S. Medjahed, S. Belaidi, S. Djekhaba, N. Tchouar, and A. Kerassa, J. Bionanosci. 10, 118 (2016).
44. K. Ouadah, N. Tchouar, S. Belaidi, O. Oukil, and M. Cinar, J. Bionanosci. 12 ,250(2018).
45. A. Kerassa, S. Belaidi, D. Harkati, T. Lanez, L. Sinha, and O. Prasad, Rev. Theor. Sci. 3, 355(2015).
46. P. Ertl, B.Rohde and P.Selzer, J. Med.Chem, 43,3714(2000).
47. V. N. Viswanadhan, A. K. Ghose, G. R. Revankar and R. K. Robins. J. Chem. Inf. Comput. sci., 29,163 (1989).
48. M. P. Edwards, and D. A. PriceAnnu. Rep. Med. Chem. 45,380 (2010).
49.PD. Leeson, B. Springthorpe.Nat. Rev. Drug. Discov., 6,881 (2007).
50. A. Tarcsay, K. Nyíri and G. M. Keseru. J. Med. Chem., 55,1252(2012).
51. T. Ryckmans, M. P. Edwards, V. A. Horne, A. M. Correia, D. R. Owen, L. R. Thompson, I. Tran, M. F. Tutt and T. Young .Bioorg. Med. Chem. Lett., 19 ,4406(2009).
52. R. A. Carr, M. Congreve, C. W. Murray, and D. C. Rees, Drug. Discov. Today 10, 987 (2005).
53. P. N. Mortenson and C. W. Murray, J. Comput. Aided. Mol. Des. 25, 663 (2011).
54. A.L. Hopkins, C.R. Groom, A. Alex, Drug Discov. Today,.9,430(2004).
55. F. Soualmia, S. Belaidi, H. Belaidi, N. Tchouar, and Z. Almi, J. Bionanosci. 11,584(2017).
56. A. Kerassa, S. Belaidi, and T. Lanez, Quantum Matter. 4, 45 (2015).
57. J. Wang, X. Q. Xie, T. Hou, and X. Xu, Fast. J. Phys. Chem. A. 24, 4443 (2007).
58. Z. Almi, S. Belaidi, and L. Segueni, Rev. Theor. Sci. 3, 264 (2015).
59. S. Belaidi, Z. Almi, and D. Bouzidi, J. Comput. Theor. Nanosci. 11, 2481 (2014).
60. H. Sklenar and J. Jager, J. Quantum. Chem. 16, 467 (1979).
61. K. Tuppurainen, S. Lotjonen, R. Laatikainen, T. Vartiainen, U. Maran, M. Strandberg, and T. Tamm, Mutat. Res. 247, 97 (1991).
62. K. J. Sanmati, J. Rahul, S. Lokesh, and K. Y. Arvind, J. Chem. Pharm. Res. 4, 3215(2012).
63.P. Liu, W. Long, Int. J. Mol. Sci. 10 (2009) 1979.
64.S. Boudergua, M. Alloui, S. Belaidi, M. Mogren Al Mogren, U.A. AbdEllatif
Ibrahim, M. Hochlaf, J. Mol. Struct. 1189(2019) 307e314.
65. I. Almi, S. Belaidi, E. Zerroug, M. Alloui, R. Ben Said, R. Linguerri, M. Hochlaf, ,J. Mol. Struct.1211 (2020) 128015
66. K. Roy, S. Kar, R.N. Das,A Primer on QSAR/QSPR Modeling, Springer Briefs in
Molecular Science. USA, (2015).
67. J.M. Díaz-Gonz_alez, F.J. Aguirre-Crespo, X. García-Mera, F.J. Prado-Prado,
MOL2NET. 1(2015) 2.
68. M. Lazar, A. Mouzdahir, M. Badia, M. Zahouily, J. Pharm. Res. 8 (2014) 119.
69. M. Larif, A. Adad, R. Hmammouchi, A.I. Taghki, A. Soulaymani, A. Elmidaoui,
M. Bouachrine, T. Lakhlifi, Arab. J. Chem. 10 (2017) 948.

Downloads

Published

2021-04-28

How to Cite

FADEL, F. Z.; TCHOUAR, N.; BELAIDI, S.; SOUALMIA, F.; OUKIL, O.; OUADAH, K. COMPUTATIONAL SCREENING AND QSAR STUDY ON A SERIES THEOPHYLLINE DERIVATIVES AS ALDH1A1 INHIBITORS. Journal of Fundamental and Applied Sciences, [S. l.], v. 13, n. 2, p. 942–964, 2021. DOI: 10.4314/jfas.v13i2.17. Disponível em: https://jfas.info/index.php/JFAS/article/view/1121. Acesso em: 30 jan. 2025.

Issue

Section

Articles